Pay in 4 interest-free payments of $5.81 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Our capabilities span national data systems such as the Vision and Eye Health Surveillance System, evaluation of chronic disease prevention initiatives, and implementation science to improve health outcomes
To get a drug FDA approved, a company must conduct phase 1, 2 and 3 clinical trials proving safety and efficacy of the compound through a laborious, multi year and extremely costly process
A 2025 systematic review by Vasireddi and colleagues in HSS Journal screened 544 published papers and identified 36 meeting inclusion criteria 35 preclinical studies and only one human study: an uncontrolled, unblinded, retrospective case series of 12 patients receiving intra-articular BPC-157 for chronic knee pain, in which 7 of 12 (58%) reported self-described relief lasting more than 6 months, with no dose, effect size, or systematically collected adverse events published
Surgery didn't work, pt didn't work, nothing worked for years
For patients first prescribed an ADM in June 2025, 72.2% filled a GLP-1 RA within 60 days
